What is the market price of Ropilastin/Romilastin? Price per unit and medical insurance coverage

Romiplostim is a recombinant thrombopoietin receptor agonist commonly used to treat thrombocytopenia, specifically immune thrombocytopenia (ITP). The drug promotes the proliferation and maturation of megakaryocytes in the bone marrow by stimulating the thrombopoietin (TPO) receptor, thereby increasing the production of platelets, helping patients increase platelet levels and reduce the risk of bleeding. Immune thrombocytopenia is a disease caused by the autoimmune system attacking and destroying platelets, causing a decrease in platelet count and increasing the risk of bleeding.

The original drug Roprostim is already on the market in China and is included in medical insurance. However, due to its short time on the market and insufficient market supply, patients may face certain difficulties in purchasing it. According to the current market price, the original drug of Ropilastin in Hong Kong, China is priced at approximately RMB 9,000 per vial, while the price of the Hong Kong version is slightly lower, approximately RMB 8,000 per vial. Please note that prices may be affected by exchange rate fluctuations, so specific prices may vary.

In other countries, such as Europe and Germany, the original drug of Roprostim is sold for about RMB 10,000 per tube. Although the price is slightly different, its drug ingredients and efficacy are basically the same as domestic and foreign versions. Although price differences exist, patients can often choose where to purchase based on their needs and ability to pay.

At present, there are no generic drugs of Roprostim in overseas markets, which makes the price of the drug relatively high and the price fluctuates greatly. Generic medicines may be a more affordable option for some patients, but currently this option is not widely available globally.

Regarding medical insurance coverage, Ropremilast has been included in China’s medical insurance system, and patients can obtain medical insurance reimbursement if they meet certain conditions. However, the specific details and coverage of medical insurance reimbursement policies are still being adjusted. Patients should consult the hospital or pharmacy for the latest medical insurance information to understand whether individuals can obtain corresponding drug cost reimbursement.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim